---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-020132"
form_type: "8-K/A"
ticker: "ZURA"
cik: "0001855644"
company_name: "Zura Bio Ltd"
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:47:42.058298+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Zura Bio files 8-K/A to correct legal exhibits; no new business disclosure

## Summary
- Amendment only restates Exhibits 5.1 (legal opinion) and 23.1 (consent) from Feb 25, 2026 8-K.
- Original 8-K covered underwriting agreement and pre-funded warrant offering.
- No changes to any financial, operational, or other substantive disclosure.

## SEC filing metadata
- accession: 0001104659-26-020132
- form_type: 8-K/A
- ticker: ZURA
- cik: 0001855644
- company_name: Zura Bio Ltd
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855644/000110465926020132/0001104659-26-020132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855644/000110465926020132/tm267392d1_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-020132
- JSON: https://secwatch.observer/filing/0001104659-26-020132.json
- Plain text: https://secwatch.observer/filing/0001104659-26-020132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.